Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Fujisawa investigates tachykinin antagonists

Jan. 24, 1997

New antiasthma agents reported by Sandoz

Jan. 24, 1997

Labopharm and Sepracor to develop solid oral form of levalbuterol

Jan. 23, 1997

New antiasthma agents from Tanabe Seiyaku

Jan. 23, 1997

SmithKline Beecham reports new antiinflammatory/antiallergic agents

Jan. 23, 1997

TBC cell adhesion inhibitor enters clinic

Jan. 22, 1997

Celltech reports new PDE IV inhibitors

Jan. 21, 1997

cAMP PDE inhibitors disclosed by Nippon Kayaku

Jan. 20, 1997

Therapeutically active glycomimetic saccharopeptides from Glycomed

Jan. 17, 1997

Schering-Plough develops dual PAF and histamine antagonist

Jan. 16, 1997

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...